Amendments to Bylaws (Form 8-K)

On December 8, 2025, EyePoint, Inc. (the "Company") filed a certificate of amendment (the "Certificate of Amendment") to its Certificate of Incorporation, as amended, solely to change the Company's name from "EyePoint Pharmaceuticals, Inc." to "EyePoint, Inc." The name change became effective on December 8, 2025. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

In connection with the name change, the Company's Board of Directors approved an amendment (the "By-lawsAmendment") to the Company's by-laws,as amended (the "By-laws"),to reflect the change in the Company's name, also effective December 8, 2025. No other changes were made to the By-laws.A copy of the By-lawsAmendment is attached as Exhibit 3.2 hereto and is incorporated herein by reference.

The Company's common stock continues to trade on the Nasdaq Global Market under the ticker symbol "EYPT."

The name change does not affect the rights of the Company's security holders, and the CUSIP number for Company's common stock will continue to be 30233G209.